Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial1 1The authors thank the women and men who participated in the study, P. E. Douziech for coordination of treatments, and the hospital pharmacists for preparation of the treatments in the trial centers.
Top Cited Papers
- 1 August 2003
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 125 (2), 328-336
- https://doi.org/10.1016/s0016-5085(03)00887-4
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Long-Term Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Colorectal AdenomasDigestion, 2000
- Prevention by aspirin and its combination with α-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colonCarcinogenesis: Integrative Cancer Research, 1999
- Aspirin use and reduced occurrence of large bowel adenomas:Gastroenterology, 1995
- Diseases preceding colon cancerDigestive Diseases and Sciences, 1994
- Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancerArchives of Internal Medicine, 1994
- Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized TrialJNCI Journal of the National Cancer Institute, 1993
- Prospective Study of the Frequency and Size Distribution of Polyps Missed by ColonoscopyJNCI Journal of the National Cancer Institute, 1990